Skin-mucous membrane disorder and therapeutic effect of pegylated liposomal doxorubicin in recurrent ovarian cancer
Author:
Affiliation:
1. Department of Obstetrics and Gynecology; Nara Medical University; Nara Japan
Publisher
Wiley
Subject
Obstetrics and Gynaecology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13334/fullpdf
Reference21 articles.
1. Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer;Mutch;J Clin Oncol,2007
2. A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japan patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer;Nakanishi;Jpn J Clin Oncol,2015
3. Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer;Gordon;J Clin Oncol,2000
4. Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse;Pujade-Lauraine;J Clin Oncol,2010
5. The role of pegylated liposomal doxorubicin in ovarian cancer: A meta-analysis of randomized clinical trials;Gibson;Oncologist,2013
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A qualitative study of the symptom management in patients with chemotherapy-induced hand-foot syndrome;2023-08-29
2. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03
3. Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients;World Journal of Clinical Cases;2021-11-26
4. Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models;International Journal of Pharmaceutics;2020-08
5. Biologicals to direct nanotherapeutics towards HER2-positive breast cancers;Nanomedicine: Nanotechnology, Biology and Medicine;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3